Random Audits Of Raw Data?

WASHINGTON—Drummond Rennie is a self-professed “fraudy”— his term for members of the coterie of journal editors, university administrators, science lobbyists, and government officials who are called on to affer testimony, give lectures, and attend meetings on science fraud. But that doesn’t mean that Rennie, deputy editor of the Journal of the American Medical Association, enjoys the title. In fact, he doesn’t think that fraud is very common within the resear

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—Drummond Rennie is a self-professed “fraudy”— his term for members of the coterie of journal editors, university administrators, science lobbyists, and government officials who are called on to affer testimony, give lectures, and attend meetings on science fraud. But that doesn’t mean that Rennie, deputy editor of the Journal of the American Medical Association, enjoys the title. In fact, he doesn’t think that fraud is very common within the research community, and he positively resents having to air what he calls “biomedicine’s dirty linen.”

But Rennie is also a realist. He recognizes the growing concern in Congress that scarce public funds are being squandered by fradulent scientists, and he understands the damage that a few well-publicized cases of serious misconduct can do to the reputation of science. He also knows that the first step in finding the answer to any problem including fraud, is to collect data.

That’s why Rennie ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies